Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07309263

Comparing the Effects of Smart App-Assited Super-Slow Jogging and Stationary Cycling on Respiratory Function and Aerobic Fitness in College Students

As health awareness continues to rise, more people are prioritizing exercise to improve physical condition and enhance overall fitness. For those lacking exercise habits, selecting a simple, accessible, and effective workout becomes crucial. Against a backdrop of prolonged sitting and inactivity, "super slow jogging" is gaining attention. This aerobic exercise involves a slow walking pace and low intensity, yet burns more calories than regular walking, making it an ideal entry-level activity for beginners or those with lower fitness levels. This study aims to investigate whether incorporating super slow jogging training can effectively enhance cardiorespiratory fitness and respiratory function, comparing its outcomes with other exercise types. The purpose of this experiment is academic research, primarily exploring the impact of exercise intervention on physiological functions. It is not intended for health screening or medical diagnosis.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Sedentary Lifestlye Young Adult

Age range

18 year–25 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • required no regular exercise training in the past six months
  • ability to safely perform high-intensity cycling exercise

Exclusion criteria

  • musculoskeletal limitations that prevented cycling exercise
  • recent infection
  • known cardiopulmonary disease or medical history affecting cardiovascular or respiratory function
  • smoking
  • use of medications that may influence cardiopulmonary responses to exercise
  • other contraindications to exercise testing according to the American College of Sports Medicine (ACSM) guidelines

Treatment and study plan

Super slow jogging

Behavioral

This study is a randomized controlled trial employing simple randomization, where participants draw lots to assign groups. The experiment comprises three groups: the super-slow jogging group, the stationary bicycle group, and the control group. Both exercise intervention groups underwent 50-minute training sessions comprising a 10-minute warm-up, 30-minute main exercise, and 10-minute cool-down.

Super-Slow Jogging Group: Utilized a smart app for pacing assistance, adjusting step frequency weekly:

Week 1: 150 steps/minute Week 2: 180 steps/minute Week 3: 190 steps/minute Week 4: 200 steps/minute Stationary Cycling Group: Participants will engage in continuous cycling training at moderate intensity (60% VO₂max).

Control Group: No exercise training intervention.

moderate exercise training

Behavioral

This study is a randomized controlled trial employing simple randomization, where participants draw lots to assign groups. The experiment comprises three groups: the super-slow jogging group, the stationary bicycle group, and the control group. Both exercise intervention groups underwent 50-minute training sessions comprising a 10-minute warm-up, 30-minute main exercise, and 10-minute cool-down.

Super-Slow Jogging Group: Utilized a smart app for pacing assistance, adjusting step frequency weekly:

Week 1: 150 steps/minute Week 2: 180 steps/minute Week 3: 190 steps/minute Week 4: 200 steps/minute Stationary Cycling Group: Participants will engage in continuous cycling training at moderate intensity (60% VO₂max).

Control Group: No exercise training intervention.

Control

Behavioral

This study is a randomized controlled trial employing simple randomization, where participants draw lots to assign groups. The experiment comprises three groups: the super-slow jogging group, the stationary bicycle group, and the control group. Both exercise intervention groups underwent 50-minute training sessions comprising a 10-minute warm-up, 30-minute main exercise, and 10-minute cool-down.

Super-Slow Jogging Group: Utilized a smart app for pacing assistance, adjusting step frequency weekly:

Week 1: 150 steps/minute Week 2: 180 steps/minute Week 3: 190 steps/minute Week 4: 200 steps/minute Stationary Cycling Group: Participants will engage in continuous cycling training at moderate intensity (60% VO₂max).

Control Group: No exercise training intervention.

Primary outcomes

  1. Cardiopulmonary Fitness

    Time frame: Before intervention and the end of intervention at 12 weeks

    VO2max (ml/kg/mL)

  2. Baseline anthropometric of the participants

    Time frame: Before intervention and the end of intervention at 12 weeks

    Age (yr)

  3. Cardiopulmonary Fitness

    Time frame: Before intervention and the end of intervention at 12 weeks

    VEmax (L/min)

  4. Cardiopulmonary Fitness

    Time frame: Before intervention and the end of intervention at 12 weeks

    AT% (%VO₂max)

  5. Cardiopulmonary Fitness

    Time frame: Before intervention and the end of intervention at 12 weeks

    Resting O₂ pulse (mL·beat-¹)

  6. Cardiopulmonary Fitness

    Time frame: Before intervention and the end of intervention at 12 weeks

    Max O₂ pulse (mL·beat-¹)

  7. Cardiopulmonary Fitness

    Time frame: Before intervention and the end of intervention at 12 weeks

    MIP (cmH2O)

  8. Cardiopulmonary Fitness

    Time frame: Before intervention and the end of intervention at 12 weeks

    MEP (cmH2O)

  9. Baseline anthropometric of the participants

    Time frame: Before intervention and the end of intervention at 12 weeks

    Height (cm)

  10. Baseline anthropometric of the participants

    Time frame: Before intervention and the end of intervention at 12 weeks

    Weight (kg)

  11. Baseline anthropometric of the participants

    Time frame: Before intervention and the end of intervention at 12 weeks

    BMI (kg/m²)

Secondary outcomes

  1. Lung function

    Time frame: Before intervention and the end of intervention at 12 weeks

    FEV1 (L)

  2. Lung function

    Time frame: Before intervention and the end of intervention at 12 weeks

    FVC (L)

  3. Lung function

    Time frame: Before intervention and the end of intervention at 12 weeks

    FEV₁/FVC (%)

  4. Lung function

    Time frame: Before intervention and the end of intervention at 12 weeks

    FEF25-75% (L·s-¹)

  5. Lung function

    Time frame: Before intervention and the end of intervention at 12 weeks

    PEF (L·min-¹)

  6. Lung function

    Time frame: Before intervention and the end of intervention at 12 weeks

    MVV (L·min-¹)

  7. Lung function

    Time frame: Before intervention and the end of intervention at 12 weeks

    Breathing reserve (%)

  8. Lung function

    Time frame: Before intervention and the end of intervention at 12 weeks

    Dynamic Index (DI%)

Study contacts

Contact information is provided by the study sponsor or research team.

Tzu-Pin Weng

CONTACT

[email protected]

+886-7-7811151-7044

Sponsors and collaborators

Lead sponsor

Fooyin University

Other

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Dec 30, 2025
Registry last updated
Dec 30, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.